MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 80 filers reported holding MYOVANT SCIENCES LTD in Q4 2019. The put-call ratio across all filers is 2.86 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $45,000 | +45.2% | 2,500 | 0.0% | 0.00% | – |
Q2 2022 | $31,000 | -6.1% | 2,500 | 0.0% | 0.00% | – |
Q1 2022 | $33,000 | -15.4% | 2,500 | 0.0% | 0.00% | – |
Q4 2021 | $39,000 | -30.4% | 2,500 | 0.0% | 0.00% | – |
Q3 2021 | $56,000 | -1.8% | 2,500 | 0.0% | 0.00% | – |
Q2 2021 | $57,000 | +11.8% | 2,500 | 0.0% | 0.00% | – |
Q1 2021 | $51,000 | -26.1% | 2,500 | 0.0% | 0.00% | – |
Q4 2020 | $69,000 | +86.5% | 2,500 | -3.8% | 0.00% | – |
Q3 2020 | $37,000 | -32.7% | 2,600 | -2.3% | 0.00% | – |
Q2 2020 | $55,000 | +5400.0% | 2,661 | +1552.8% | 0.00% | – |
Q1 2020 | $1,000 | -50.0% | 161 | +61.0% | 0.00% | – |
Q4 2019 | $2,000 | -95.0% | 100 | -94.3% | 0.00% | – |
Q2 2018 | $40,000 | +8.1% | 1,750 | 0.0% | 0.00% | – |
Q1 2018 | $37,000 | +68.2% | 1,750 | 0.0% | 0.00% | – |
Q4 2017 | $22,000 | -18.5% | 1,750 | 0.0% | 0.00% | – |
Q3 2017 | $27,000 | +35.0% | 1,750 | 0.0% | 0.00% | – |
Q2 2017 | $20,000 | -4.8% | 1,750 | 0.0% | 0.00% | – |
Q1 2017 | $21,000 | -4.5% | 1,750 | 0.0% | 0.00% | – |
Q4 2016 | $22,000 | – | 1,750 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NovaQuest Capital Management, L.L.C. | 3,474,645 | $53,926,000 | 68.07% |
Eventide Asset Management | 4,126,131 | $64,038,000 | 1.80% |
VHCP Management III, LLC | 455,255 | $7,066,000 | 1.40% |
Ghost Tree Capital, LLC | 450,000 | $6,984,000 | 1.33% |
Cormorant Asset Management, LP | 2,000,000 | $31,040,000 | 1.24% |
Bellevue Group AG | 4,815,109 | $74,730,000 | 1.18% |
Values First Advisors, Inc. | 72,417 | $1,124,000 | 1.08% |
Parkman Healthcare Partners LLC | 99,413 | $1,543,000 | 0.44% |
Matisse Capital | 32,750 | $508,000 | 0.36% |
VHCP Management II, LLC | 76,768 | $1,191,000 | 0.31% |